Skip to Main Content

Paper Details

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.
J Natl Cancer Inst
26
2019
BMI-associated variants, BRCA1, BRCA1/2, BRCA1/2 Mutation, BRCA1/2 mutation, BRCA1/2 mutations, BRCA2, BRCA2 mutation, Breast Cancer, breast cancer, cancer, height-associated variants, premenopausal breast cancer
Author NameAffiliation
Wendy K ChungColumbia University
Wendy K ChungColumbia University
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Javier Ben??tezJonsson Comprehensive Cancer Center, University of California Los Angeles
Ian G CampbellPeter MacCallum Cancer Center
Ian G CampbellThe University of Melbourne
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Susan M DomchekAbramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Rosalind A EelesThe Institute of Cancer Research and Royal Marsden NHS Foundation Trust
Judy E GarberCancer Risk and Prevention Clinic, Dana-Farber Cancer Institute
Jacek GronwaldMaastricht University Medical Center
Jacek GronwaldMaastricht University Medical Center
Peter J HulickCenter for Medical Genetics, NorthShore University HealthSystem
Peter J HulickThe University of Chicago Pritzker School of Medicine
Peter J HulickCenter for Medical Genetics, NorthShore University HealthSystem
Peter J HulickThe University of Chicago Pritzker School of Medicine
Claudine IsaacsLombardi Comprehensive Cancer Center, Georgetown University
Louise IzattClinical Genetics, Guy's and St Thomas' NHS Foundation Trust
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Jeong-Won LeeUlsan University College of Medicine and Asan Medical Center
Jenny LesterMaastricht University Medical Center
Jan LubinskiMaastricht University Medical Center
Jan LubinskiMaastricht University Medical Center
Patrick J MorrisonQueens University Belfast
Robert L NussbaumUniversity of California San Francisco
Paolo RadiceFondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT)
Susan J RamusUniversity of New South Wales Sydney
Susan J RamusThe Kinghorn Cancer Centre, Garvan Institute of Medical Research
Susan J RamusUniversity of New South Wales Sydney
Susan J RamusThe Kinghorn Cancer Centre, Garvan Institute of Medical Research
Gustavo C RodriguezNorthShore University HealthSystem, University of Chicago
Mary Beth TerryMailman School of Public Health, Columbia University
Christi J van AsperenLeiden University Medical Center
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
David E GoldgarHuntsman Cancer Institute, University of Utah School of Medicine
David E GoldgarHuntsman Cancer Institute, University of Utah School of Medicine
Timothy R RebbeckHarvard T.H. Chan School of Public Health
Timothy R RebbeckDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 45

Datasets